4.5 Article

Dendritic cells modulate c-kit expression on the edge between activation and death

Journal

EUROPEAN JOURNAL OF IMMUNOLOGY
Volume 49, Issue 4, Pages 534-545

Publisher

WILEY
DOI: 10.1002/eji.201847683

Keywords

conventional dendritic cell subsets; dendritic cell survival; CpG; PolyI; C; Stem cell factor

Categories

Funding

  1. Ministero dell'Universita e delle Ricerca (MIUR) [CTN01 00177 962865]

Ask authors/readers for more resources

Dendritic cells (DCs) are key players in immunity and tolerance. Some DCs express c-kit, the receptor for stem cell factor (SCF), nevertheless c-kit functional role and the regulation of its expression in DCs are incompletely defined. We recently demonstrated that autocrine SCF sustains a pro-survival circuit, and that SCF increases phospho-AKT in c-kit+ mouse bone marrow-derived DCs (BMdDCs). Herein we observed that CpG and PolyI:C, two stimuli mimicking bacterial and viral nucleic acids respectively, strongly inhibited c-kit expression by BMdDCs and spleen DCs in vitro and in vivo. Experiments in IFNARI(-/-) mice showed that IFN-I pathway was required for c-kit down-regulation in cDC1s, but only partially supported it in cDC2s. Furthermore, CpG and PolyI:C strongly inhibited c-kit mRNA expression. In agreement with the reduced c-kit levels, SCF pro-survival activity was impaired. Thus in the presence of exogenously provided SCF, either PolyI:C or CpG induced spleen DC death in 2 days, while at earlier times IL-6 and IL-12 production were slightly increased. In contrast, SCF improved survival of unstimulated spleen DCs expressing high c-kit levels. Our studies suggest that c-kit down-modulation is a previously neglected component of DC response to CpG and PolyI:C, regulating DC survival and ultimately tuning immune response.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Hematology

Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency

Francesco Saettini, Cecilia Poli, Jaime Vengoechea, Sonia Bonanomi, Julio C. Orellana, Grazia Fazio, Fred H. Rodriguez, Loreani P. Noguera, Claire Booth, Valentina Jarur-Chamy, Marissa Shams, Maria Iascone, Maja Vukic, Serena Gasperini, Manuel Quadri, Amairelys Barroeta Seijas, Elizabeth Rivers, Mario Mauri, Raffaele Badolato, Giovanni Cazzaniga, Cristina Bugarin, Giuseppe Gaipa, Wilma G. M. Kroes, Daniele Moratto, Monique M. van Ostaijen-ten Dam, Frank Baas, Silvere van der Maarel, Rocco Piazza, Zeynep H. Coban-Akdemir, James R. Lupski, Bo Yuan, Ivan K. Chinn, Lucia Daxinger, Andrea Biondi

Summary: Agammaglobulinemia, recurrent infections, hypertrophic cardiomyopathy and neutropenia were found in three novel patients in this study. Variants in the gene for folliculin interacting protein 1 (FNIP1) were identified, leading to impaired B-cell metabolism and development. This study highlights the importance of FNIP1 in B-cell development and metabolism.

BLOOD (2021)

Article Multidisciplinary Sciences

A DNA/Ki67-Based Flow Cytometry Assay for Cell Cycle Analysis of Antigen-Specific CD8 T Cells in Vaccinated Mice

Sonia Simonetti, Ambra Natalini, Giovanna Peruzzi, Alfredo Nicosia, Antonella Folgori, Stefania Capone, Angela Santoni, Francesca Di Rosa

Summary: The study describes a flow cytometric method for capturing antigen-specific T cells in different cell cycle phases by combining Ki67 and DNA staining with MHC-peptide-multimer staining. This method enables successful differentiation between CD8 T cells in G(0), G(1), and S-G(2)/M phases, providing potential for increased understanding of T cell response in vivo and improved immuno-monitoring analysis.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2021)

Review Biochemistry & Molecular Biology

Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models

Alessio Gerussi, Ambra Natalini, Fabrizio Antonangeli, Clara Mancuso, Elisa Agostinetto, Donatella Barisani, Francesca Di Rosa, Raul Andrade, Pietro Invernizzi

Summary: Drug-induced liver injury (DILI) is a challenging clinical event with various phenotypes and limited diagnostic and therapeutic tools. Recent advancements in genomics and immunology offer insights into the molecular aspects of DILI, helping to improve understanding and research in this field.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

Leticia Monin, Adam G. Laing, Miguel Munoz-Ruiz, Duncan R. McKenzie, Irene Del Molino Del Barrio, Thanussuyah Alaguthurai, Clara Domingo-Vila, Thomas S. Hayday, Carl Graham, Jeffrey Seow, Sultan Abdul-Jawad, Shraddha Kamdar, Elizabeth Harvey-Jones, Rosalind Graham, Jack Cooper, Muhammad Khan, Jennifer Vidler, Helen Kakkassery, Shubhankar Sinha, Richard Davis, Liane Dupont, Isaac Francos Quijorna, Charlotte O'Brien-Gore, Puay Ling Lee, Josephine Eum, Maria Conde Poole, Magdalene Joseph, Daniel Davies, Yin Wu, Angela Swampillai, Bernard North, Ana Montes, Mark Harries, Anne Rigg, James Spicer, Michael H. Malim, Paul Fields, Piers Patten, Francesca Di Rosa, Sophie Papa, Timothy Tree, Katie J. Doores, Adrian C. Hayday, Sheeba Irshad

Summary: The study aimed to evaluate the safety and immunogenicity of the BNT162b2 vaccine in cancer patients. The results showed poor efficacy of a single vaccine dose in cancer patients, with significantly increased immunogenicity in solid cancer patients after a vaccine boost at day 21. Therefore, it is recommended to prioritize cancer patients for an early second dose on day 21.

LANCET ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Exploiting natural antiviral immunity for the control of pandemics: Lessons from Covid-19

Eleonora Arico, Laura Bracci, Luciano Castiello, Francesca Urbani, Jean-Laurent Casanova, Filippo Belardelli

Summary: The outbreak of COVID-19 highlights the importance of the innate immune response and the role of type I interferons in antiviral defense. Deficient type I interferon activity contributes to disease progression, and early therapeutic use of IFN-beta and prophylactic campaigns with live attenuated vaccines may prevent future pandemics.

CYTOKINE & GROWTH FACTOR REVIEWS (2022)

Review Biochemical Research Methods

COVID-19: Using high-throughput flow cytometry to dissect clinical heterogeneity

Irene del Molino del Barrio, Thomas S. Hayday, Adam G. Laing, Adrian C. Hayday, Francesca Di Rosa

Summary: This article discusses the use of high-content flow cytometric methodology to rapidly provide meaningful biological data in COVID-19 studies. High-throughput flow cytometry helps identify immune signatures and investigate the impact of SARS-CoV-2 exposure on cancer patients. Integration of flow cytometry data with other metrics can differentiate the immune profiles of COVID-19 patients from healthy donors and non-COVID respiratory infection patients.

CYTOMETRY PART A (2023)

Article Health Care Sciences & Services

Molecular Analysis in a Glioblastoma Cohort-Results of a Prospective Analysis

Liverana Lauretti, Tonia Cenci, Nicola Montano, Martina Offi, Martina Giordano, Valerio M. Caccavella, Antonella Mangraviti, Ludovico Agostini, Alessandro Olivi, Lucia Gabriele, Luigi M. Larocca, Roberto Pallini, Maurizio Martini, Quintino Giorgio D'Alessandris

Summary: The prognostic role of EGFRvIII in glioblastoma is controversial. However, this study found no association between EGFRvIII and worsened prognosis. Interestingly, female sex was found to be associated with better outcomes.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Oncology

An Orthotopic Patient-Derived Xenograft (PDX) Model Allows the Analysis of Metastasis-Associated Features in Colorectal Cancer

Maria Laura De Angelis, Federica Francescangeli, Chiara Nicolazzo, Eljona Xhelili, Filippo La Torre, Lidia Colace, Alessandro Bruselles, Daniele Macchia, Sara Vitale, Paola Gazzaniga, Marta Baiocchi, Ann Zeuner

Summary: Metastasis is the leading cause of death in colorectal cancer patients, making it imperative to develop preclinical models that can replicate the process of metastasis at the individual patient level. In this study, an orthotopic patient-derived xenograft (PDX) model was established by directly implanting freshly dissociated colorectal cancer cells into the colon of immunocompromised mice. The findings suggest that ortho-PDX can be a useful preclinical model to study metastasis-related features and demonstrate that the epithelial-to-mesenchymal transition and stemness properties of primary colorectal tumors may play a crucial role in tumor engraftment.

FRONTIERS IN ONCOLOGY (2022)

Article Biochemistry & Molecular Biology

Mouse dendritic cells in the steady state: Hypoxia, autophagy, and stem cell factor

Amairelys Belen Barroeta Seijas, Sonia Simonetti, Irene Filippi, Antonella Naldini, Gabriele Favaretto, Teresa Colombo, Ambra Natalini, Fabrizio Antonangeli, Mattia Laffranchi, Silvano Sozzani, Angela Santoni, Francesca Di Rosa

Summary: Dendritic cells (DCs) play a crucial role in immunity and tolerance, and studies have found that DCs exhibit a hypoxic phenotype in the spleen and bone marrow. DCs expressing membrane c-kit, the receptor for stem cell factor, showed higher hypoxic marker intensity under low oxygen conditions.

CELL BIOCHEMISTRY AND FUNCTION (2022)

Article Immunology

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Martina Musella, Andrea Guarracino, Nicoletta Manduca, Claudia Galassi, Eliana Ruggiero, Alessia Potenza, Ester Maccafeo, Gwenola Manic, Luca Mattiello, Sara Soliman Abdel Rehim, Michele Signore, Marco Pietrosanto, Manuela Helmer-Citterich, Matteo Pallocca, Maurizio Fanciulli, Tiziana Bruno, Francesca De Nicola, Giacomo Corleone, Anna Di Benedetto, Cristiana Ercolani, Edoardo Pescarmona, Laura Pizzuti, Francesco Guidi, Francesca Sperati, Sara Vitale, Daniele Macchia, Massimo Spada, Giovanna Schiavoni, Fabrizio Mattei, Adele De Ninno, Luca Businaro, Valeria Lucarini, Laura Bracci, Eleonora Arico, Giovanna Ziccheddu, Francesco Facchiano, Stefania Rossi, Massimo Sanchez, Alessandra Boe, Mauro Biffoni, Ruggero De Maria, Ilio Vitale, Antonella Sistigu

Summary: The study demonstrates that type I interferons can promote the formation of cancer stem cells by upregulating the chromatin remodeling factor KDM1B. Inhibition of KDM1B could potentially prevent stem cell expansion and increase the long-term benefit of therapy.

NATURE IMMUNOLOGY (2022)

Review Oncology

Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe

Luciano Castiello, Laura Santodonato, Mariarosaria Napolitano, Davide Carlei, Enrica Montefiore, Domenica Maria Monque, Giuseppina D'Agostino, Eleonora Arico

Summary: Despite success in hematology, chimeric antigen receptor T cell therapies have shown limited progress in treating solid tumors. Multiple factors, including the heterogeneity of solid tumors and difficulties in identifying reliable tumor antigens, contribute to this slower pace. Currently, different CAR therapies are being investigated, with varying construction types, engineered cells, and additional signals to overcome solid tumor barriers. Novel approaches are also being developed to address limitations seen in approved therapies. This review analyzes the advantages and challenges of these different approaches, considering both scientific evidence and manufacturing/regulatory issues for further clinical development.

CANCERS (2022)

Review Biochemistry & Molecular Biology

Durable CD8 T Cell Memory against SARS-CoV-2 by Prime/Boost and Multi-Dose Vaccination: Considerations on Inter-Dose Time Intervals

Ambra Natalini, Sonia Simonetti, Carmel Sher, Ugo D'Oro, Adrian C. Hayday, Francesca Di Rosa

Summary: Anti-SARS-CoV-2 memory CD8 T cells induced by vaccination play an important role in mitigating the COVID-19 pandemic. Vaccination with two or more doses can promote the differentiation of memory CD8 T cells, and the length of inter-dose intervals may influence the magnitude and persistence of CD8 T cell memory.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Meeting Abstract Immunology

The TDS assay: a powerful tool for detecting ongoing T cell responses by peripheral blood sampling

Ambra Natalini, Sonia Simonetti, Giovanna Peruzzi, Miguel Munoz Ruiz, Leticia Monin, Irma Pujol Autonell, Hefin Rhys, Heather M. Long, Adrian C. Hayday, Francesca Di Rosa

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

No Data Available